Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients
- PMID: 11779672
- DOI: 10.1016/s0885-3924(01)00367-0
Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients
Abstract
Three terminal cancer patients with severe dyspnea were treated with nebulized furosemide. The underlying causes of dyspnea varied. Twenty milligrams of furosemide was nebulized and inhaled four times each day. Dyspnea dramatically improved and could be controlled for weeks. No noticeable side effects were observed. Inhalation of nebulized furosemide seems to be an effective and useful treatment for dyspnea in terminal cancer patients, but these observations need to be confirmed in a randomized controlled trial.
Comment in
-
Re: nebulized furosemide for dyspnea in terminal cancer patients.J Pain Symptom Manage. 2002 Sep;24(3):274-5; author reply 275-6. doi: 10.1016/s0885-3924(02)00479-7. J Pain Symptom Manage. 2002. PMID: 12458098 Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
